Free Trial

Kyverna Therapeutics (KYTX) Earnings Date, Estimates & Call Transcripts

$9.41
-0.30 (-3.09%)
(As of 07/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 14)
-$1.12 Missed By -$0.28
Consensus EPS
(May. 14)
-$0.84
Skip Charts & View Estimated and Actual Earnings Data

KYTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KYTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kyverna Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.20)($1.20)($1.20)
Q2 20241($0.69)($0.69)($0.69)
Q3 20241($0.83)($0.83)($0.83)
Q4 20241($0.98)($0.98)($0.98)
FY 20244($3.70)($3.70)($3.70)

KYTX Earnings Date and Information

Kyverna Therapeutics last announced its quarterly earnings data on May 14th, 2024. The reported ($1.12) EPS for the quarter, missing the consensus estimate of ($0.84) by $0.28. Kyverna Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Kyverna Therapeutics are expected to decrease in the coming year, from ($3.34) to ($3.83) per share. Kyverna Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Kyverna Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/14/2024Q1 2024($0.84)($1.12)($0.28)($1.12)$3.75 million-

Kyverna Therapeutics Earnings - Frequently Asked Questions

When is Kyverna Therapeutics's earnings date?

Kyverna Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on KYTX's earnings history.

Did Kyverna Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Kyverna Therapeutics (NASDAQ:KYTX) missed the analysts' consensus estimate of ($0.84) by $0.28 with a reported earnings per share (EPS) of ($1.12). Learn more on analysts' earnings estimate vs. KYTX's actual earnings.

How much revenue does Kyverna Therapeutics generate each year?

Kyverna Therapeutics (NASDAQ:KYTX) has a recorded annual revenue of $7.03 million.

How much profit does Kyverna Therapeutics generate each year?

Kyverna Therapeutics (NASDAQ:KYTX) has a recorded net income of -$60.37 million. KYTX has generated $0.00 earnings per share over the last four quarters.

What is Kyverna Therapeutics's EPS forecast for next year?

Kyverna Therapeutics's earnings are expected to decrease from ($3.34) per share to ($3.83) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:KYTX) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners